GeneVentiv Therapeutics

Raleigh, United States

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.

$2.5M raised

Apr 2024

Grant

Biopharma Biotechnology Health Care

Top Investors

National Heart Lung and Blood Institute Innovate Carolina

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GeneVentiv Therapeutics

How much funding has GeneVentiv Therapeutics raised?

GeneVentiv Therapeutics has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in April 2024.

Who are GeneVentiv Therapeutics's investors?

GeneVentiv Therapeutics's investors include National Heart, Lung and Blood Institute, Innovate Carolina.

Where is GeneVentiv Therapeutics headquartered?

GeneVentiv Therapeutics is headquartered in Raleigh, United States.

What does GeneVentiv Therapeutics do?

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.

What stage is GeneVentiv Therapeutics at?

GeneVentiv Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2024.

MLA

"GeneVentiv Therapeutics — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/geneventiv-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). GeneVentiv Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/geneventiv-therapeutics

Wikipedia (cite web)

{{cite web |title=GeneVentiv Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/geneventiv-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2024.